ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Discover The Value Your eTMF Should Deliver

  A well-prepared Trial Master File (TMF) is critical to the success of any clinical trial. Because the TMF tells the whole story of a study – including every data point collected and decision made – managing it throughout the course of the trial is challenging.

• How eConsent Delivers Value For Sponsors

  Delve into the data substantiating experiences with electronic informed consent to better understand their positive impact on the outcomes of clinical trials.

• eCOA In Oncology Trials: A Tool To Simplify

  Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.

• Better eConsent Through Education Best Practices

  eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.

• Building A Gold Standard Trial Experience In Japan

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• EHR Integration: Driving Clinical Trial Efficiency

  Explore how clinical trials are integrating Electronic Health Records (EHRs) into trial workflows to better face the increasing demands for efficiency, cost reduction, and improved participant experiences.

• Webinar Recap: How EDC Can Support Modern Clinical Trials

  Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.

• Digital Health Solution For CRS Detection And Prediction

  Explore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.

• The Final DCT Guidance: I'm Not Mad At It

  Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.

• Parkinson's Disease: Leveraging Wearable DHTs

  Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.